Critics question study on stents, others doubt much impact

03/28/2007 | NYTimes.com · Wall Street Journal, The

Some critics of a trial showing drugs should be tried before angioplasty note only 3% of participants with stents received the latest drug-coated models. Still, there remain questions about whether the study will have much impact on the market for stents, which is already experiencing a sag in sales because of recent safety concerns.

View Full Article in:

NYTimes.com · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC